Cleared Abbreviated

K003362 - ASTRONOMER+WITH SLD

K003362 is an FDA 510(k) clearance for ASTRONOMER+WITH SLD, manufactured by Boston Scientific Corp. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Abbreviated 510(k) pathway after a 125-day FDA review.

K003362 · Boston Scientific Corp · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2001
Decision
125d
Days
Class 2
Risk

K003362 is an FDA 510(k) clearance for the ASTRONOMER+WITH SLD. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Boston Scientific Corp (San Jose, US). The FDA issued a Cleared decision on March 1, 2001 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Boston Scientific Corp devices

FDA 510(k) Submission Details - K003362

510(k) Number K003362 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 2000
Decision Date March 01, 2001
Days to Decision 125 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 125d · This submission: 125d
Pathway characteristics
Standards-based clearance path.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 359
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K003362.
CAMBRIDGE HEART MODEL CH 2000 CARDIAC DIAGNOSTIC SYSTEM
K011324 · Cambridge Heart, Inc. · May 2001
SYNETEC
K002817 · Ela Medical, Inc. · May 2001
CH 2000 CARDIAC DIAGNOSTIC SYSTEM
K010756 · Cambridge Heart, Inc. · Apr 2001
ANALYTIC SPECTRAL METHOD OF ALTERNANS PROCESSING
K003492 · Cambridge Heart, Inc. · Jan 2001
CATHCOR DESKTOP
K002137 · Siemens Elema AB · Oct 2000
MAC-LAB SYSTEM AND CARDIOLAB EP SYSTEM
K001305 · General Electric Medical Systems Information Techn · Jun 2000